Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: NZ$0.73 M
• Last 3 months FTD volume: NZ$15.02 M
• Last 12 months FTD volume: NZ$47.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$56.63 M	NZ$0.12 B	🇺🇸 USA
GSK plc GSK	NZ$26.89 M	NZ$0.35 B	🇬🇧 UK
Sarepta Therapeutics SRPT	NZ$5.28 M	NZ$23.03 M	🇺🇸 USA
PTC Therapeutics PTCT	NZ$13.79 M	NZ$18.93 M	🇺🇸 USA
Fate Therapeutics FATE	NZ$0.04 M	NZ$1.33 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	NZ$0.01 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	NZ$0.43 M	NZ$0.78 M	🇺🇸 USA